We want our patients to focus on their health instead of coverage, so we’ve created a specially trained Patient Access Team that handles all insurance and financing matters throughout their course of treatment.

When TMS therapy or esketamine nasal spray has been prescribed for treatment, the Patient Access Team assesses coverage and provides financing options for those without insurance. For the insured, we perform a thorough benefits investigation and work diligently to obtain insurance pre-authorization for services, including the sometimes complicated task of securing approval for TMS or esketamine. We also submit and process claims for all therapies and provide support as any coverage issues or questions about insurance arise.

Our patient experience has been carefully considered from the moment they walk in the door through the conclusion of their treatment. Our architect-designed clinics feature pleasant, modern, and welcoming reception and waiting areas. Similarly, treatment and consult rooms are warm, calm and natural spaces, providing an inspiring and relaxing, non-clinical environment throughout the course of the multiple visits required for effective treatment.

We partner with a patient’s psychiatrist, primary care provider, or therapist to help ensure the best possible treatment outcomes. We work with patients to create a treatment plan, confer with their referring clinicians to gather information and records, and make sure treatment expectations are aligned. As treatment progresses, we regularly update referring clinicians to provide feedback as to their patient’s progress. At the conclusion of the TMS treatment course or course of esketamine nasal spray, we provide a final report for the referring physician and check in with the patient as needed.

To continually improve our practice and best serve our patients, we believe in getting granular. Our team tracks our patients’ treatment and progress with tools such as the PHQ-9 screen, using confidential methods to ensure anonymity. We regularly review each patient’s responsiveness and use the data to adjust their treatment. We also aggregate the information to help us gain a deeper understanding of our practice’s overall effectiveness, and guide us as we improve our procedures and expand our range of therapy options. We present our progress and findings at conferences, trainings, and on our website.

We believe that transparent reporting methods strengthen our patient relationships and advances public discussion and understanding of depression and other mental health conditions.

To continually improve our practice and best serve our patients, we believe in getting granular. Our team tracks our patients’ treatment and progress with tools such as the PHQ-9 screen, using confidential methods to ensure anonymity. We regularly review each patient’s responsiveness and use the data to adjust their treatment. We also aggregate the information to help us gain a deeper understanding of our practice’s overall effectiveness, and guide us as we improve our procedures and expand our range of therapy options. We present our progress and findings at conferences, trainings, and on our website.

We believe that transparent reporting methods strengthen our patient relationships and advances public discussion and understanding of depression and other mental health conditions.